CEESAY ABRAHAM (Chief Executive Officer) sold 1.0% of their position (4.52K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $143.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/8/2026ACC: 0001193125-26-417919
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-4.52K
Net shares
Net seller
$143.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.38K
Price / share
$32.03
Trade value
$108.11K
% of position
0.7%
10/6/2026
456.77K→453.39K
Common Stock
Direct
Shares
−1.15K
Price / share
$30.66
Trade value
$35.17K
% of position
0.3%
10/7/2026
453.39K→452.25K
Total
Net shares
−4.52K
Net value
-$143.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/6/2026 | S · Sale | −3.38K | $32.03 | $108.11K | 0.7% | 456.77K | 453.39K |
| Common Stock Direct | 10/7/2026 | S · Sale | −1.15K | $30.66 | $35.17K | 0.3% | 453.39K | 452.25K |
| Total | −4.52K | -$143.27K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned20.73K
Common Stock
IndirectShares owned81.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.73K | Indirect |
| Common Stock | 81.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported